transprk outcomes in virgin eyes treated with the ... · • post op up to 5 days...
TRANSCRIPT
"TransPRK outcomes in virgin eyes
treated with the Aberration-Free
profile and AMARIS 500Hz laser
technology"
Ants Haavel MD
KSA Eye Center
Tallinn, Estonia
TransPRK - message to patients
• New Generation Laser Procedure
• No Touch
• No Cut
• First choice laser treatment for young myopes
• Precise
• Excellent vision quality
• Safe
• Convenient
• Real 100% laser treatment
Pre operative exam
• Refraction: objective, subjective, cycloplegic
• Scheimpflug, topography, pachymetry
• Pupillometry: scotopic, mesoptic and photopic
• IOP
• Biomicroscopy
• Funduscopy
• Health and lifestyle questionnaire
• Patient education, expectations and post op time line of visual recovery
Decision for TransPRK vs. LASIK
TransPRK
• myope under 38 y.o
• active lifestyle
• interested more in long than
short term benefits
• healthy
LASIK
• myope over 38 y.o
• interested in rapid recovery
• healthy
Medication protocol
• Pre op: starting 2 days before C vitamin 400 mg 2xd and
Levofloxacin 0,5 % eye drops 4xd
• Intra op: Alcaine 0,5 % , Chilled PVC sponge ( 20 sec. post ablation ),
Mitomycin 0,02% ( 90 sec. post ablation ), Acular 0,5%,
Levofloxacin 0,5% , Dexamethasone 0,5 %, Oasys Hydraclear CL
• Post op up to 5 days Chloramphenicol-Dexamethasone 0,5 % 3xd ,
Acular 3xd , non preservative artificial tears every 30 minutes
during wake up hours. Remove contact lenses 5-7 days post op not
earlier.
• Post op up to 2 months Dexamethasone 0,5% next 2 months post
op. 1 week 4xd; 2-3 week 3xd , 4-8 week 2xd. C vitamin 400 mg
b.i.d. 2 weeks post op. Artificial tears if requested.
Op video
05/12/11
Optional follow-up schedule
• 5-7 days post op remove contact lenses
• 1 M objective refraction, visual acuity
• 3 M objective & subjective refraction
• 6 M objective & subjective refraction
• 12 M months objective & subjective refraction
• 1 year in next years
Average values and ranges pre operative
in 49 patients (98 eyes)
Optical Zone
Mean ± StDev Range
Ast [D]
UCVA [logMAR]
UCVA [20/n]
Age
BCVA [logMAR]
BCVA [20/n]
28,08 ± 5,74
6,85 ± 0,32
-0,58 ± 0,63
0,95 ± 0,39
20/200++
-3,41 ± 1,48SEq [D]
20/20
19 to 40
6,30 to 7,50
-6,75 to -0,50
-2,90 to 0,00
0,10 to 1,60
20/25 to 20/800
-0,20 to 0,10
20/10 to 20/25
0,00 ± 0,04
4%6%
62%
24%
4%
0%
20%
40%
60%
loss 2 loss 1 unchanged gain 1 gain 2
monocular 3M (98 eyes)
Safety: PreOp BCVA vs. PostOp BCVA
2% 3%4%
26%
96%
92%
100%98%
100% 100%
0%
20%
40%
60%
80%
100%
20/12,5 or
better
20/16 or
better
20/20 or
better
20/25 or
better
20/32 or
better
preOP BCVA postOP UCVA 3M
Cumulative PreOp BCVA vs. PostOp UCVA
Scattergram: Defocus
y = 1,05x + 0,12
R2 = 0,93
0
1
2
3
4
5
6
7
8
9
0 1 2 3 4 5 6 7 8 9Attempted SEQ [D]
Achieved [D]
overcorrected
undercorrected
Scattergram: Astigmatism
y = 0,92x + 0,06
R2 = 0,86
0
1
2
3
4
0 1 2 3 4
Attempted Cyl [D]
Achieved [D]
overcorrected
undercorrected
Accuracy: Defocus
52%
60%
73%
83%
94%
100%
0%
20%
40%
60%
80%
100%
±0.1
3 D
±0.2
5 D
±0.5
0 D
±0.7
5 D
±1.0
0 D
±1.2
5 D
Accuracy in Defocus 3M (98 eyes)
Accuracy: Astigmatism
71%
82%
96%100%
0%
20%
40%
60%
80%
100%
±0.1
3 D
±0.2
5 D
±0.5
0 D
±0.7
5 D
Accuracy in Cylinder 3M (98 eyes)
Refractive Summary
3-month post operative in 49 patients
Mean±StDev Range
Seq [D]
Ast [D]
UCVA [logMAR]
UCVA [20/n]
BCVA [logMAR]
BCVA [20/n]
-0,20 to 0,20
20/10 to 20/32
-0,13 ± 0,22
-0,02 ± 0,07
20/20+
-0,02 ± 0,07
-0,38 to 1,25
-0,75 to 0,00
-0,20 to 0,20
20/10 to 20/32
20/20+
0,31 ± 0,42
TransPRK gives cornea more energy load than conventional surface ablations.
Extend your conventional surface ablation MMC, NSAID and dexamethasone treatment times.
Educate patients to relax and look into laser during extended ablation times.
Adjustment of clinical protocol
Marketing of Trans PRK
• You can change name of TransPRK for more customer friendly and attractive trade name which is suitable for your market and practice.
• New generation non touch laser procedure for new generation people.
• Premium product positioned and priced higher as Femto LASIK.
• Position it as treatment for intelligent, educated and open minded people.
• Young active people really prefer gradual visual recovery to avoid having life time cut in the cornea.
• Due plasticity of young tissues and accommodation abilities patients have high satisfaction rate, relatively quick visual recovery and real life is usually better than numbers in “Datagraph”.
Conclusion
• Highly patient driven No Touch No Cut laser procedure for treating myopia which rises practice’s revenue and profitability.
• Lower overhead gives practice more resources for investments andmarketing budget.
• Surface ablations need more time for educating patients and pro active communication from laser center personnel.
• TransPRK success = patient education, exact pre-op refraction and exams, precise laser technology, pro active communication, customized nomogram and adjusted clinical-medication protocol.
Welcome to TransPRK World!